Beyond CDH1 Mutations: Causes of Hereditary Diffuse Gastric Cancer

作者: Samantha Hansford , David Huntsman

DOI: 10.1007/978-94-007-6570-2_9

关键词: CDH1CancerGeneHereditary diffuse gastric cancerDiseaseDNA sequencingBiologyGene DiscoveryComputational biology

摘要: Since highly penetrant CDH1 mutations were described in hereditary diffuse gastric cancer, such mutants have attributed to roughly 40 % of cases. However, the molecular basis remaining 60 families, defined by clinical parameters, remains be determined. Significant advances sequencing technologies past several years improved all aspects gene discovery; including accuracy and analysis data, speed with which data is analyzed overall cost sequencing. Specifically, progress high-throughput methodologies that allow for more targeted interesting genes, along ability sequence many samples a single run, account considerable breakthroughs made disease research, cancer. To this day, most significant attributing familial patterns utilizing latest next generation examining non-CDH1 carrying researchers hope identify gene(s) these cases at faster efficient rate.

参考文章(38)
Kyle R. Pomraning, Kristina M. Smith, Erin L. Bredeweg, Lanelle R. Connolly, Pallavi A. Phatale, Michael Freitag, Library Preparation and Data Analysis Packages for Rapid Genome Sequencing Fungal Secondary Metabolism. ,vol. 944, pp. 1- 22 ,(2012) , 10.1007/978-1-62703-122-6_1
Richard W Tothill, Maria A Doyle, Cliff Meldrum, Next-Generation Sequencing for Cancer Diagnostics: a Practical Perspective The Clinical biochemist. Reviews / Australian Association of Clinical Biochemists. ,vol. 32, pp. 177- 195 ,(2011)
Pauline C. Ng, Ewen F. Kirkness, Whole Genome Sequencing Methods in Molecular Biology. ,vol. 628, pp. 215- 226 ,(2010) , 10.1007/978-1-60327-367-1_12
Alba Rocco, Laslo Schandl, Jie Chen, Hongbing Wang, Zsolt Tulassay, Deirdre McNamara, Peter Malfertheiner, Matthias P. A. Ebert, Loss of FHIT protein expression correlates with disease progression and poor differentiation in gastric cancer Journal of Cancer Research and Clinical Oncology. ,vol. 129, pp. 84- 88 ,(2003) , 10.1007/S00432-002-0409-3
Parry Guilford, Justin Hopkins, James Harraway, Maybelle McLeod, Ngahiraka McLeod, Pauline Harawira, Huriana Taite, Robin Scoular, Andrew Miller, Anthony E. Reeve, E-cadherin germline mutations in familial gastric cancer Nature. ,vol. 392, pp. 402- 405 ,(1998) , 10.1038/32918
Emily M. Coonrod, Jacob D. Durtschi, Rebecca L. Margraf, Karl V. Voelkerding, Developing Genome and Exome Sequencing for Candidate Gene Identification in Inherited Disorders: An Integrated Technical and Bioinformatics Approach Archives of Pathology & Laboratory Medicine. ,vol. 137, pp. 415- 433 ,(2013) , 10.5858/ARPA.2012-0107-RA
Laura E. MacConaill, Levi A. Garraway, Clinical Implications of the Cancer Genome Journal of Clinical Oncology. ,vol. 28, pp. 5219- 5228 ,(2010) , 10.1200/JCO.2009.27.4944
Giovanni Corso, Daniele Marrelli, Valeria Pascale, Carla Vindigni, Franco Roviello, Frequency of CDH1 germline mutations in gastric carcinoma coming from high- and low-risk areas: metanalysis and systematic review of the literature BMC Cancer. ,vol. 12, pp. 8- 17 ,(2012) , 10.1186/1471-2407-12-8
Pardeep Kaurah, Andrée MacMillan, Niki Boyd, Janine Senz, Alessandro De Luca, Nicki Chun, Gianpaolo Suriano, Sonya Zaor, Lori Van Manen, Cathy Gilpin, Sarah Nikkel, Mary Connolly-Wilson, Scott Weissman, Wendy S. Rubinstein, Courtney Sebold, Robert Greenstein, Jennifer Stroop, Dwight Yim, Benoit Panzini, Wendy McKinnon, Marc Greenblatt, Debrah Wirtzfeld, Daniel Fontaine, Daniel Coit, Sam Yoon, Daniel Chung, Gregory Lauwers, Antonio Pizzuti, Carlos Vaccaro, Maria Ana Redal, Carla Oliveira, Marc Tischkowitz, Sylviane Olschwang, Steven Gallinger, Henry Lynch, Jane Green, James Ford, Paul Pharoah, Bridget Fernandez, David Huntsman, Founder and Recurrent CDH1 Mutations in Families With Hereditary Diffuse Gastric Cancer JAMA. ,vol. 297, pp. 2360- 2372 ,(2007) , 10.1001/JAMA.297.21.2360